Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/SEAGEN-INC-10808/news/Seattle-Genetics-and-Astellas-Announce-Results-from-Phase-1-Trial-of-Investigational-Agent-Enfortu-29273851/?utm_source=whatsapp&utm_medium=social&utm_campaign=share